S&P Removes Pershing Square from CreditWatch Negative as Valeant (VRX) Stabilizes
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Valeant Pharma (VRX) Shares Squeeze to Session Highs
July 6, 2016 12:24 PM EDTValeant Pharma (NYSE: VRX) shares continue to power higher Wednesday. The stock is up well over 8.5 percent with robust volume.
Notably, short interest was at 32.6 million shares, or 9.8 percent of float, at the middle of last month. That was an... More
